JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 12, 2003; DOI: 10.1124/jpet.103.050062


0022-3565/03/3063-870-879$20.00
JPET 306:870-879, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.050062v1
306/3/870    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onn, S.-P.
Right arrow Articles by Grace, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onn, S.-P.
Right arrow Articles by Grace, A. A.

CELLULAR AND MOLECULAR

Dopamine Modulation of Membrane Excitability in Striatal Spiny Neurons is Altered in DARPP-32 Knockout Mice

Shao-Pii Onn, Allen A. Fienberg, and Anthony A. Grace

Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.-P.O.); Laboratory of Molecular and Cellular Neuroscience, the Rockefeller University, New York, New York (A.A.F.); Departments of Neuroscience and Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania (A.A.G.)

The phosphoprotein DARPP-32 (dopamine and cAMP-regulated phosphoprotein 32 kDa) plays a central role in mediating the actions of a variety of neurotransmitters in medium spiny neurons of the striatum (Greengard, 1990; Fienberg et al., 1998). This study examines D1 and D2 dopamine (DA) agonist effects on the membrane properties of identified striatal neurons recorded in slices obtained from wild-type and DARPP-32-knockout mice. In wild-type spiny cells, DA D1 receptor activation decreased cell excitability, causing a 58.8 ± 13.5% increase in rheobase current required to evoke spike discharge. In contrast, D1 agonist administration did not alter cell excitability when applied to spiny cells in slices prepared from the DARPP-32 knockout mice. D2 agonist administration decreased cell excitability in both wild-type and knockout mice. The response produced by combined D1 and D2 agonist stimulation was dependent on the sequence of agonist administration. Thus, the D1 agonist-induced decrease in excitability was reversed to a facilitation of spiking upon subsequent D2 agonist administration. In contrast, D2 agonist applied simultaneously with the D1 agonist only produced a reduction in excitability. This type of D1-dependent modulation was not present in slices from the DARPP-32 knockout mice.


Received for publication February 5, 2003
Accepted May 29, 2003.

Address correspondence to: Dr. Shao-Pii Onn, 288 Queen Lane, Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, PA 19129. E-mail: shao-pii.onn{at}drexel.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. V. Zhdanov, M. W. Ward, J. H. M. Prehn, and D. B. Papkovsky
Dynamics of Intracellular Oxygen in PC12 Cells upon Stimulation of Neurotransmission
J. Biol. Chem., February 29, 2008; 283(9): 5650 - 5661.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Chen, J. D. Bohanick, M. Nishihara, J. K. Seamans, and C. R. Yang
Dopamine D1/5 Receptor-Mediated Long-Term Potentiation of Intrinsic Excitability in Rat Prefrontal Cortical Neurons: Ca2+-Dependent Intracellular Signaling
J Neurophysiol, March 1, 2007; 97(3): 2448 - 2464.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.